Immediate Impact
6 from Science/Nature 63 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
2024 Standout
Works of Sarah Paul being referenced
Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results.
2018
Blood-based biomarkers for cancer immunotherapy: Tumor mutational burden in blood (bTMB) is associated with improved atezolizumab (atezo) efficacy in 2L+ NSCLC (POPLAR and OAK)
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sarah Paul | 119 | 167 | 137 | 224 | 18 | 522 | |
| Amir Aghajanian | 63 | 65 | 74 | 128 | 15 | 610 | |
| Atsushi Kaibara | 72 | 69 | 63 | 134 | 22 | 522 | |
| Elisabetta Trevellin | 46 | 76 | 40 | 229 | 21 | 533 | |
| Beatriz Morancho | 75 | 183 | 38 | 140 | 19 | 628 | |
| Emma L. Shepherd | 55 | 58 | 43 | 95 | 24 | 612 | |
| Qian Zhao | 50 | 81 | 106 | 113 | 23 | 479 | |
| Ting Huang | 37 | 117 | 73 | 143 | 31 | 586 | |
| Mads Malik Aagaard | 84 | 78 | 18 | 192 | 20 | 566 | |
| Ju Hee Lee | 40 | 62 | 52 | 259 | 17 | 560 | |
| Byung‐Hyun Park | 38 | 70 | 60 | 97 | 15 | 525 |
All Works
Loading papers...